Benson Edagwa
Professor at UNMC, Community Pride of Nebraska Endowed Professor, NSRI Fellow and Co-Founder, Exavir Therapeutics Inc. & Aion Medicines
- Role
- Co-founder, Aion Medicines at Aion Medicines
- Location
- Omaha, NE, US
- LinkedIn followers
- 500 followers
About Benson Edagwa
We are focused on transforming frequently administered therapies into novel ultra-long acting safe medicines that can be dosed once every six months to once a year to facilitate treatment and prevention of persistent illnesses such as HIV infection, viral hepatitis, tuberculosis, malaria, addiction to opiates and cardiometabolic diseases. The ultimate goal of this work is to facilitate therapy completion rates. The strong interdisciplinary team in our research program and infrastructure is something that few other programs enjoy and a major advantage towards the success of our research goals and student mentorship.Selected Issued/Pending Patents (from over 84 US and Worldwide Patents and Patent Applications)1. Edagwa BJ; Gendelman HE,\"Antiviral Prodrugs and Formulations Thereof,\" US Patent SN 62/772,852. International Publication Number WO 2020/112931 A12. Edagwa BJ; Gendelman HE,\"Antiviral Prodrugs and Formulations Thereof,\" US Patent SN 62/654,723. International Publication Number WO 2019/199756 A13. Edagwa BJ; Gendelman HE,\"Antiviral Prodrugs and Formulations Thereof,\" US Patent SN 62/616,549. International Publication Number WO 2019/140365 A1.4. Edagwa BJ; Gendelman H.E; Johns B.A,”Compositions and Methods for the Delivery of Antiviral Therapeutics,\" US Patent SN 62/353,736. International Publication Number WO2017/223280 A2.5. Gendelman H.E; Liu X. M; Edagwa BJ,\"Compositions and Methods for the Delivery of Therapeutics,\" US Patent SN 62/061,759. International Publication Number WO2016/057866 A1.6. Khalili, K; Gendelman H.E; Edagwa BJ.\"Combination of gene editing agent and CRISPR-Cas9 and long-acting antiretroviral agents for the treatment of HIV infection,\" US Patent SN 62/814,591. Publication Number US 2021/00•••38 A17. Edagwa BJ; Gendelman H.E,\"Antiviral Prodrugs and Formulations Thereof,\" US Patent SN 62/748,798. International Publication Number: A18. Edagwa BJ; Gendelman H.E,\"Prodrugs of a thiazolide and formulations thereof,\" US Patent SN 62/890,194. International Publication Number: WO2021/035114 A19. Edagwa BJ; Gendelman HE,\"Phosphonate Prodrugs and Use Thereof,\" US Patent SN 63/200,686.10. Edagwa BJ; Gendelman HE,\"Antiviral Prodrugs and Use Thereof,\" US Patent SN 63/200,685.
Experience
Co-founder, Aion Medicines
Mar 2025 — Present
Education
Louisiana State University
Doctor of Philosophy (PhD)
Skills
- Nmr
- Mass Spectrometry
- Medicinal Chemistry
- Science
- Lc-Ms
- Scifinder
- Neuroscience
- Western Blotting
- Microscopy
- Molecular Modeling
- Immunohistochemistry
- Drug Delivery
- Statistics
- Analytical Chemistry
- Maldi-Tof
- Biocatalysis
- Chemdraw
- Natural Product/Total Synthesis
- Nanoformulations
- Computational Chemistry
- Chromatography
- Pharmacokinetics
- Uv/Vis Spectroscopy
- Asymmetric Catalysis
- Cell Culture
- Column Chromatography
- Hplc
- Confocal Microscopy
- In Vitro & in Vivo Studies
- Uv/Vis
- Protein Chemistry
- Drug Design
- Fluorescence
- Characterization
- Spectroscopy
- Drug Discovery
- Organic Synthesis
- Nmr Spectroscopy
- Molecular Biology
- Fluorescence Microscopy
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.